Immobility responses between mouse strains correlate with distinct hippocampal serotonin transporter protein expression and function

International Journal of Neuropsychopharmacology

Volumn 17, Issue 11, 2014, Pages 1737-1750

  Tang, Man ^a   He, Tao ^a   Meng, Qing Yan ^b   Broussard, John Isaac ^c   Yao, Lan ^d   Diao, Yao ^a   Sang, Xiu Bo ^a   Liu, Qing Peng ^a   Liao, Ying Jun ^a   Li, Yuge ^a   Zhao, Shulei ^e  

^a CHINA MEDICAL UNIVERSITY   (China)

^b Northern Hospital   (China)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d Shenyang Hospital of Traditional Chinese Medicine   (China)

^e UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

Forced swimming test; hippocampal subregions; mouse strain difference; serotonin transporter; tail suspension test

Indexed keywords

FLUOXETINE; SEROTONIN TRANSPORTER; SEROTONIN; SEROTONIN UPTAKE INHIBITOR; SLC6A4 PROTEIN, MOUSE; TRITIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDEPRESSANT ACTIVITY; ARTICLE; BEHAVIOR; CONTROLLED STUDY; FORCED SWIM TEST; HIPPOCAMPAL CA1 REGION; HIPPOCAMPAL CA3 REGION; IMMOBILITY; LOCOMOTION; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; STRAIN DIFFERENCE; TAIL SUSPENSION TEST; ANALYSIS OF VARIANCE; ANIMAL; DOSE RESPONSE; DRUG EFFECTS; HIPPOCAMPUS; IMMOBILIZATION; METABOLISM; PHYSIOLOGY; PSYCHOLOGY; SCINTISCANNING; SPECIES DIFFERENCE; STATISTICS; SWIMMING; SYNAPTOSOME; TONIC IMMOBILITY;

ANALYSIS OF VARIANCE; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUOXETINE; HINDLIMB SUSPENSION; HIPPOCAMPUS; IMMOBILITY RESPONSE, TONIC; LOCOMOTION; MALE; MICE; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SEROTONIN UPTAKE INHIBITORS; SPECIES SPECIFICITY; STATISTICS AS TOPIC; SWIMMING; SYNAPTOSOMES; TRITIUM;

EID: 84924811780     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S146114571400073X     Document Type: Article

References (71)

1. Adriani W, Macri S, Pacifici R, Laviola G (2002) Peculiar vulnerability to nicotine oral self-administration in mice during early adolescence. Neuropsychopharmacology 27:212-224.
2. Airan RD, Meltzer LA, Roy M, Gong Y, Chen H, Deisseroth K (2007) High-speed imaging reveals neurophysiological links to behavior in an animal model of depression. Science 317:819-823.
3. Ansah TA, Ramamoorthy S, Montanez S, Daws LC, Blakely RD (2003) Calcim-dependent inhibition of synaptosomal serotonin transport by the alph2-adrenoceptor agonist 5-bro-N-[4,5-dihydro-1H-imidazol-2-yl]-6-quinoxalinamine (UK14304). J Pharmacol Exp Ther 305:956-965.
4. Audet MC, Anisman H (2010) Neuroendocrine and neurochemical impact of aggressive social interactions in submissive and dominant mice: implications for stress-related disorders. Int J Neuropsychopharmacol 13:361-372.
5. Audet MC, Jacobson-Pick S, Wann BP, Anisman H (2011) Social defeat promotes specific cytokine variations within the prefrontal cortex upon subsequent aggressive or endotoxin challenges. Brain Behav Immun 25:1197-1205.
6. Bai F, Li X, Clay M, Lindstrom T, Skolnick P (2001) Intra- and interstrain differences in models of "behavioral despair". Pharmacol Biochem Behav 70:187-192.
7. Bampton ET, Gray RA, Large CH (1999) Electrophysiological characterisation of the dentate gyrus in five inbred strains of mouse. Brain Res 841:123-134.
8. Berton O, Nestler EJ (2006) New approaches to antidepressant drug discovery: beyond monoamines. Nat Rev Neurosci 7:137-151.
9. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
10. Can A, Piantadosi SC, Gould TD (2013) Differential antidepressant-like response to lithium treatment between mouse strains: effects of sex, maternal care, and mixed genetic background. Psychopharmacol (Berl) 228:411-418.
11. Carola V, Gross C (2012) Mouse models of the 5-HTTLPR x stress risk factor for depression. Curr Top Behav Neurosci 12:59-72.
12. Carola V, Frazzetto G, Pascucci T, Audero E, Puglisi-Allegra S, Cabib S, Lesch KP, Gross C (2008) Identifying molecular substrates in a mouse model of the serotonin transporter x environment risk factor for anxiety and depression. Biol Psychiatry 63:840-846.
13. Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H, McClay J, Mill J, Martin J, Braithwaite A, Poulton R (2003) Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 301:386-389.
14. Crawley JN, Belknap JK, Collins A, Crabbe JC, Frankel W, Henderson N, Hitzemann RJ, Maxson SC, Miner LL, Silva AJ, Wehner JM, Wynshaw-Boris A, Paylor R (1997) Behavioral phenotypes of inbred mouse strains: implications and recommendations for molecular studies. Psychopharmacol (Berl) 132:107-124.
15. Crusio WE, Bar IM, Schwegler H, Buselmaier W (1990) A multivariate morphometric analysis of hippocampal anatomical variation in C57BL/6 in equilibrium BALB/c chimeric mice. Brain Res 535:343-346.
16. Cryan JF, Mombereau C (2004) In search of a depressed mouse: utility of models for studying depression-related behavior in genetically modified mice. Mol Psychiatry 9:326-357.
17. Cryan JF, Slattery DA (2007) Animal models of mood disorders: recent developments. Curr Opin Psychiatry 20:1-7.
18. Cryan JF, Hoyer D, Markou A (2003) Withdrawal from chronic amphetamine induces depressive-like behavioral effects in rodents. Biol Psychiatry 54:49-58.
19. Cryan JF, Mombereau C, Vassout A (2005) The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice. Neurosci Biobehav Rev 29:571-625.
20. Daniele A, Divella R, Paradiso A, Mattioli V, Romito F, Giotta F, Casamassima P, Quaranta M (2011) Serotonin transporter polymorphism in major depressive disorder (MDD), psychiatric disorders, and in MDD in response to stressful life events: causes and treatment with antidepressant. In Vivo 25:895-901.
21. David DJ, Renard CE, Jolliet P, Hascoet M, Bourin M (2003) Antidepressant-like effects in various mice strains in the forced swimming test. Psychopharmacol (Berl) 166:373-382.
22. Ducottet C, Griebel G, Belzung C (2003) Effects of the selective nonpeptide corticotrophin-releasing factor receptor 1 antagonist antalarmin in the chronic mild stress model of depression in mice. Prog Neuropsychopharmacol Biol Psychiatry 27:625-631.
23. Gylys KH, Fein JA, Cole GM (2000) Quantitative characterization of crude synaptosomal fraction (P-2) components by flow cytometry. J Neurosci Res 61:186-192.
24. Hagan CE, McDevitt RA, Liu Y, Furay AR, Neumaier JF (2012) 5-HT(1B) autoreceptor regulation of serotonin transporter activity in synaptosomes. Synapse 66:1024-1034.
25. Herman JP, Cullinan WE, Morano MI, Akil H, Watson SJ (1995) Contribution of the ventral subiculum to inhibitory regulation of the hypothalamo-pituitary-adrenocortical axis. J Neuroendocrinol 7:475-482.
26. Homanics GE, Quinlan JJ, Firestone LL (1999) Pharmacologic and behavioral responses of inbred C57BL/6J and strain 129/SvJ mouse lines. Pharmacol Biochem Behav 63:21-26.
27. Horiuchi Y, Ishikawa M, Kaito N, Iijima Y, Tanabe Y, Ishiguro H, Arinami T (2013) Experimental evidence for the involvement of PDLIM5 in mood disorders in Hetero Knockout Mice. PLoS ONE 8:e59320. Doi:10.1371/journal.pone.0059320.
28. Isingrini E, Belzung C, Freslon JL, Machet MC, Camus V (2012) Fluoxetine effect on aortic nitric oxide-dependent vasorelaxation in the unpredictable chronic mild stress model of depression in mice. Psychosom Med 74:63-72.
29. Jiang W, Zhang Y, Xiao L, Van Cleemput J, Ji SP, Bai G, Zhang X (2005) Cannabinoids promote embryonic and adult hippocampus neurogenesis and produce anxiolytic- and antidepressant-like effects. J Clin Invest 115:3104-3116.
30. Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR, Rush AJ, Walters EE, Wang PS (2003) The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). Jama 289:3095-3105.
31. Kim JI et al. (2011) PI3Kgamma is required for NMDA receptor-dependent long-term depression and behavioral flexibility. Nat Neurosci 14:1447-1454.
32. Krishnan V, Nestler EJ (2008) The molecular neurobiology of depression. Nature 455:894-902.
33. Ledesma JC, Aragon CM (2012) alpha-Lipoic acid, a scavenging agent for H(2)O(2), reduces ethanol-stimulated locomotion in mice. Psychopharmacol (Berl) 219:171-180.
34. Lein ES, Zhao X, Gage FH (2004) Defining a molecular atlas of the hippocampus using DNA microarrays and high-throughput in situ hybridization. J Neurosci 24:3879-3889.
35. Liu X, Peprah D, Gershenfeld HK (2003) Tail-suspension induced hyperthermia: a new measure of stress reactivity. J Psychiatr Res 37:249-259.
36. Livy DJ, Wahlsten D (1991) Tests of genetic allelism between four inbred mouse strains with absent corpus callosum. J Hered 82:459-464.
37. Logue SF, Owen EH, Rasmussen DL, Wehner JM (1997) Assessment of locomotor activity, acoustic and tactile startle, and prepulse inhibition of startle in inbred mouse strains and F1 hybrids: implications of genetic background for single gene and quantitative trait loci analyses. Neuroscience 80:1075-1086.
38. Lucki I, Dalvi A, Mayorga AJ (2001) Sensitivity to the effects of pharmacologically selective antidepressants in different strains of mice. Psychopharmacol (Berl) 155:315-322.
39. Mayorga AJ, Lucki I (2001) Limitations on the use of the C57BL/6 mouse in the tail suspension test. Psychopharmacol (Berl) 155:110-112.
40. McQuaid RJ, Audet MC, Anisman H (2012) Environmental enrichment in male CD-1 mice promotes aggressive behaviors and elevated corticosterone and brain norepinephrine activity in response to a mild stressor. Stress 15:354-360.
41. McQuaid RJ, Audet MC, Jacobson-Pick S, Anishman H (2013a) The differential impact of social defeat on mice living in isolation or groups in an enriched environment: plasma corticosterone and monoamine variations. Int J Neuropsychopharmacol 16:351-363.
42. McQuaid RJ, Audet MC, Jacobson-Pick S, Anisman H (2013b) Environmental enrichment influences brain cytokine variations elicited by social defeat in mice. Psychoneuroendocrinol 38:987-996.
43. Miczek KA, Yap JJ, Covington HE III (2008) Social stress, therapeutics and drug abuse: preclinical models of escalated and depressed intake. Pharmacol Ther 120:102-128.
44. Miner LL (1997) Cocaine reward and locomotor activity in C57BL/6J and 129/SvJ inbred mice and their F1 cross. Pharmacol Biochem Behav 58:25-30.
45. Miner LL, Collins AC (1989) Strain comparison of nicotine-induced seizure sensitivity and nicotinic receptors. Pharmacol Biochem Behav 33:469-475.
46. Moser MB, Moser EI (1998) Functional differentiation in the hippocampus. Hippocampus 8:608-619.
47. O'Neill B, Gu HH (2013) Amphetamine-induced locomotion in a hyperdopaminergic ADHD mouse model depends on genetic background. Pharmacol Biochem Behav 103:455-459.
48. Owen EH, Logue SF, Rasmussen DL, Wehner JM (1997) Assessment of learning by the Morris water task and fear conditioning in inbred mouse strains and F1 hybrids: implications of genetic background for single gene mutations and quantitative trait loci analyses. Neuroscience 80:1087-1099.
49. Paylor R, Crawley JN (1997) Inbred strain differences in prepulse inhibition of the mouse startle response. Psychopharmacol (Berl) 132:169-180.
50. Petit-Demouliere B, Chenu F, Bourin M (2005) Forced swimming test in mice: a review of antidepressant activity. Psychopharmacol (Berl) 177:245-255.
51. Pitkanen A, Pikkarainen M, Nurminen N, Ylinen A (2000) Reciprocal connections between the amygdala and the hippocampal formation, perirhinal cortex, and postrhinal cortex in rat. Ann NY Acad Sci 911:369-391.
52. Pollak DD, Rey CE, Monje FJ (2010) Rodent models in depression research: classical strategies and new directions. Ann Med 42:252-264.
53. Porcelli S, Fabbri C, Serretti A (2012) Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with antidepressant efficacy. Eur Neuropsychopharmacol 22:239-258.
54. Porsolt RD, Le Pichon M, Jalfre M (1977) Depression: a new animal model sensitive to antidepressant treatments. Nature 266:730-732.
55. Pothion S, Bizot JC, Trovero F, Belzung C (2004) Strain differences in sucrose preference and in the consequences of unpredictable chronic mild stress. Behav Brain Res 155:135-146.
56. Ripoll N, David DJ, Dailly E, Hascoet M, Bourin M (2003) Antidepressant-like effects in various mice strains in the tail suspension test. Behav Brain Res 143:193-200.
57. Santarelli L, Saxe M, Gross C, Surget A, Battaglia F, Dulawa S, Weisstaub N, Lee J, Duman R, Arancio O, Belzung C, Hen R (2003) Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 301:805-809.
58. Seale TW, McLanahan K, Johnson P, Carney JM, Rennert OM (1984) Systematic comparison of apomorphine-induced behavioral changes in two mouse strains with inherited differences in brain dopamine receptors. Pharmacol Biochem Behav 21:237-244.
59. Steru L, Chermat R, Thierry B, Simon P (1985) The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacol (Berl) 85:367-370.
60. Stiedl O, Radulovic J, Lohmann R, Birkenfeld K, Palve M, Kammermeier J, Sananbenesi F, Spiess J (1999) Strain and substrain differences in context- and tone-dependent fear conditioning of inbred mice. Behav Brain Res 104:1-12.
61. Sugimoto Y, Kajiwara Y, Hirano K, Yamada S, Tagawa N, Kobayashi Y, Hotta Y, Yamada J (2008) Mouse strain differences in immobility and sensitivity to fluvoxamine and desipramine in the forced swimming test: analysis of serotonin and noradrenaline transporter binding. Eur J Pharmacol 592:116-122.
62. Sugimoto Y, Yamamoto M, Tagawa N, Kobayashi Y, Mitsui-Saitoh K, Hotta Y, Yamada J (2011) Differences between mice strains in response to paroxetine in the forced swimming test: involvement of serotonergic or noradrenergic systems. Eur J Pharmacol 672:121-125.
63. Tang M, Lei J, Sun X, Liu G, Zhao S (2013) Stress-induced anhedonia correlates with lower hippocampal serotonin transporter protein expression. Brain Res 1513:127-134.
64. Tang M, He T, Sun X, Meng QY, Diao Y, Lei JY, He XJ, Chen L, Sang XB, Zhao S (2014) Subregion-specific decreases in hippocampal serotonin transporter protein expression and function associated with endophenotypes of depression. Hippocampus 24:493-501.
65. Tolliver BK, Carney JM (1994) Sensitization to stereotypy in DBA/2J but not C57BL/6J mice with repeated cocaine. Pharmacol Biochem Behav 48:169-173.
66. Võikar V, Koks S, Vasar E, Rauvala H (2001) Strain and gender differences in the behavior of mouse lines commonly used in transgenic studies. Physiol Behav 72:271-281.
67. Wainwright P, Deeks S (1984) A comparison of corpus callosum development in the BALB/cCF and C57BL/6J inbred mouse strains. Growth 48:192-197.
68. Yadav R, Hillman BG, Gupta SC, Suryavanshi P, Bhatt JM, Pavuluri R, Stairs DJ, Dravid SM (2013) Deletion of glutamate delta-1 receptor in mouse leads to enhanced working memory and deficit in fear conditioning. PLoS ONE 8:e60785. Doi:10.1371/journal.pone.0060785.
69. Yan HC, Cao X, Das M, Zhu XH, Gao TM (2010) Behavioral animal models of depression. Neurosci Bull 26:327-337.
70. Zhao Y, Ma R, Shen J, Su H, Xing D, Du L (2008) A mouse model of depression induced by repeated corticosterone injections. Eur J Pharmacol 581:113-120.
71. Zhu CB, Lindler KM, Owens AW, Daws LC, Blakely RD, Hewlett WA (2010) Interleukin-1 receptor activation by systemic lipopolysaccharide induces behavioral despair linked to MAPK regulation of CNS serotonin transporters. Neuropsychopharmacol 35:2510-2520.